These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37314924)

  • 1. Protocol for purification of cells in their native state using reversible aptamer-antidote pairs.
    Requena MD; Gray BP; Sullenger BA
    STAR Protoc; 2023 Sep; 4(3):102348. PubMed ID: 37314924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers as Reversible Sorting Ligands for Preparation of Cells in Their Native State.
    Gray BP; Requena MD; Nichols MD; Sullenger BA
    Cell Chem Biol; 2020 Feb; 27(2):232-244.e7. PubMed ID: 31879266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson's disease.
    Pavia-Collado R; Miquel-Rio L; Campa L; Bortolozzi A
    STAR Protoc; 2022 Jun; 3(2):101445. PubMed ID: 35707681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annealing and purification of fluorescently labeled DNA substrates for in vitro assays.
    Tse YWE; Yun HY; Wyatt HDM
    STAR Protoc; 2023 Mar; 4(1):102128. PubMed ID: 36853679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol of living cell separation using the microfluidic dielectrophoresis integrated chip.
    Koba K; Yarimizu K; Fujiyoshi S; Oshiro K; Wakizaka Y; Takano M; Maruyama F
    STAR Protoc; 2022 Sep; 3(3):101527. PubMed ID: 35779257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidote control of aptamer therapeutics: the road to a safer class of drug agents.
    Bompiani KM; Woodruff RS; Becker RC; Nimjee SM; Sullenger BA
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1924-34. PubMed ID: 22352726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of universal antidotes to control aptamer activity.
    Oney S; Lam RT; Bompiani KM; Blake CM; Quick G; Heidel JD; Liu JY; Mack BC; Davis ME; Leong KW; Sullenger BA
    Nat Med; 2009 Oct; 15(10):1224-8. PubMed ID: 19801990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenic cell selection and substrate rigidity manipulation using 2D and 3D extracellular matrices.
    Zhang J; Ha W; Chang Y; Ge Y; Wei X; Tan Y; Jia Q
    STAR Protoc; 2022 Sep; 3(3):101577. PubMed ID: 35880125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.
    Dyke CK; Steinhubl SR; Kleiman NS; Cannon RO; Aberle LG; Lin M; Myles SK; Melloni C; Harrington RA; Alexander JH; Becker RC; Rusconi CP
    Circulation; 2006 Dec; 114(23):2490-7. PubMed ID: 17101847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
    Bompiani KM; Monroe DM; Church FC; Sullenger BA
    J Thromb Haemost; 2012 May; 10(5):870-80. PubMed ID: 22385910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol to isolate live single cells while retaining spatial information by combining cell photolabeling and FACS.
    Baldominos P; Barreiro O; von Andrian U; Sirera R; Montero-Llopis P; Agudo J
    STAR Protoc; 2022 Dec; 3(4):101795. PubMed ID: 36325581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of five different primary cell types from a single sample of human skin.
    Kabacik S; Lowe D; Cohen H; Felton S; Spitzer J; Raj K
    STAR Protoc; 2022 Jun; 3(2):101378. PubMed ID: 35586317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.
    Ciardiello F; Caputo R; Troiani T; Borriello G; Kandimalla ER; Agrawal S; Mendelsohn J; Bianco AR; Tortora G
    Int J Cancer; 2001 Jul; 93(2):172-8. PubMed ID: 11410862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial delivery of antisense locked nucleic acids for silencing microRNAs in the mouse brain.
    Sharma N; Sen GC
    STAR Protoc; 2022 Dec; 3(4):101836. PubMed ID: 36595897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol to isolate human normal and neoplastic pancreatic cells for single-cell omic analyses.
    Chen H; Peng J; Liu L; Huang D; Zhao Y; Wu W
    STAR Protoc; 2023 Sep; 4(3):102464. PubMed ID: 37480562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
    Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC
    Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A low-cost and open-source protocol to produce key enzymes for molecular detection assays.
    Mendoza-Rojas G; Sarabia-Vega V; Sanchez-Castro A; Tello L; Cabrera-Sosa L; Nakamoto JA; Peñaranda K; Adaui V; Alcántara R; Milón P
    STAR Protoc; 2021 Dec; 2(4):100899. PubMed ID: 34766029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for isolation of spermatids from mouse testes.
    Kim CR; Noda T; Okada Y; Ikawa M; Baek SH
    STAR Protoc; 2021 Mar; 2(1):100254. PubMed ID: 33490974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor.
    Chan MY; Rusconi CP; Alexander JH; Tonkens RM; Harrington RA; Becker RC
    J Thromb Haemost; 2008 May; 6(5):789-96. PubMed ID: 18284597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of glioblastoma cell growth following antisense oligonucleotide-mediated inhibition of fibroblast growth factor receptor expression.
    Yamada SM; Yamaguchi F; Brown R; Berger MS; Morrison RS
    Glia; 1999 Oct; 28(1):66-76. PubMed ID: 10498824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.